Is Staphylococcal Screening and Suppression an Effective Interventional Strategy for Reduction of Surgical Site Infection?

Surgical Infections
Charles E EdmistonDavid Leaper

Abstract

Staphylococcus aureus has been recognized as a major microbial pathogen for over 100 y, having the capacity to produce a variety of suppurative and toxigenic disease processes. Many of these infections are life-threatening, with particularly enhanced virulence in hospitalized patients with selective risk factors. Strains of methicillin-resistant Staphylococcus aureus (MRSA) have rapidly spread throughout the healthcare environment such that approximately 20% of S. aureus isolates recovered from surgical site infections are methicillin-resistant, (although this is now reducing following national screening and suppression programs and high impact interventions). Widespread nasal screening to identify MRSA colonization in surgical patients prior to admission are controversial, but selective, evidence-based studies have documented a reduction of surgical site infection (SSI) after screening and suppression. Culture methods used to identify MRSA colonization involve selective, differential, or chromogenic media. These methods are the least expensive, but turnaround time is 24-48 h. Although real-time polymerase chain reaction (RT-PCR) technology provides rapid turnaround (1-2 h) with exceptional testing accuracy, the costs can range...Continue Reading

References

Nov 1, 1978·Archives of Internal Medicine·N KirmaniJ N Sheagren
Jul 1, 1987·Diabetes Care·B A LipskyT D Koepsell
Jan 1, 1995·The Journal of Infectious Diseases·J A KluytmansH A Verbrugh
Jul 1, 1996·The Journal of Hospital Infection·R M ParnabyM S Shafi
Feb 27, 1999·Annals of Internal Medicine·M H NguyenV L Yu
Dec 30, 1999·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C CunyW Witte
May 24, 2000·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·M D KalmeijerG A de Baere
Jun 14, 2002·The New England Journal of Medicine·Trish M PerlUNKNOWN Mupirocin And The Risk Of Staphylococcus Aureus Study Team
Jul 30, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M D KalmeijerJ A J W Kluytmans
Jun 6, 2003·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Carlene A MutoUNKNOWN SHEA
Aug 5, 1961·British Medical Journal·R J HENDERSON, R E WILLIAMS
Dec 23, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Evelina TacconelliErika M C D'Agata
Jul 10, 2004·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Loreen A HerwaldtTrish M Perl
Oct 9, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jan L NouwenHenri A Verbrugh
Oct 27, 2004·Infection and Immunity·Jan NouwenHenri Verbrugh
Mar 17, 2005·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Ulla BalslevHenrik Westh
Nov 29, 2005·The Lancet Infectious Diseases·Heiman F L WertheimJan L Nouwen
Jan 19, 2006·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Alexander J KallenRobin J Larson
May 26, 2006·International Wound Journal·David J LeaperAnne Berger
Oct 19, 2006·International Journal of Antimicrobial Agents·I M Gould
Dec 6, 2006·The Journal of Hospital Infection·R CunninghamS Hunt
Feb 28, 2007·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Stephen G WeberUNKNOWN Association of Professionals in Infection Control and Epidemiology
Aug 29, 2007·The Journal of Thoracic and Cardiovascular Surgery·Rafael San JuanJose Maria Aguado
Nov 28, 2007·The British Journal of Surgery·M R S KeshtgarA P R Wilson
Dec 8, 2007·American Journal of Infection Control·William R JarvisMarguerite Jackson
Jan 19, 2008·Joint Commission Journal on Quality and Patient Safety·Lance R PetersonAri Robicsek
Mar 13, 2008·JAMA : the Journal of the American Medical Association·Stephan HarbarthDidier Pittet
May 22, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Katharine L McGinigleIan B Buchanan
Jan 16, 2009·Journal of Clinical Microbiology·Julie CarsonJeff Fuller
May 30, 2009·Journal of the American College of Surgeons·Walter E PofahlMichael F Rotondo
Aug 14, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jean B PatelJohn A Jernigan
Nov 6, 2009·Journal of Clinical Microbiology·Jess F PetersonNathan A Ledeboer
Jan 8, 2010·The New England Journal of Medicine·Lonneke G M BodeMargreet C Vos
Jan 15, 2010·Journal of Clinical Microbiology·Lance R Peterson, Daniel J Diekema

❮ Previous
Next ❯

Citations

Apr 27, 2016·Seminars in Vascular Surgery·Tazo Inui, Dennis F Bandyk
Feb 18, 2017·American Journal of Obstetrics and Gynecology·Holly L Steiner, Eric A Strand
Apr 28, 2017·Surgical Infections·Paul K Waltz, Brian S Zuckerbraun
Apr 30, 2019·Surgical Infections·Philip S BarieRobert G Sawyer
Mar 16, 2019·Frontiers in Microbiology·Ana Maria Nunes BotelhoAgnes Marie Sá Figueiredo
Mar 7, 2018·Journal of Wound Care·Steven JefferyJohn Lantis
May 11, 2020·The Annals of Thoracic Surgery·Krish C DewanEdward G Soltesz
Aug 27, 2021·AORN Journal·Lisa Spruce

❮ Previous
Next ❯

Methods Mentioned

BETA
amputation
nucleic acid amplification
PCR

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.